milrinone has been researched along with Thrombocytopenia in 4 studies
Thrombocytopenia: A subnormal level of BLOOD PLATELETS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients were maintained on milrinone therapy for as long as 8 weeks and demonstrated a low incidence of adverse cardiac (7%) or noncardiac (4%) events." | 6.68 | Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. ( Kapoor, C; Mehra, MR; Smart, FW; Stapleton, DD; Ventura, HO; Zimmerman, D, 1997) |
| " Patients were maintained on milrinone therapy for as long as 8 weeks and demonstrated a low incidence of adverse cardiac (7%) or noncardiac (4%) events." | 2.68 | Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. ( Kapoor, C; Mehra, MR; Smart, FW; Stapleton, DD; Ventura, HO; Zimmerman, D, 1997) |
| " We identified adverse events (AEs) during milrinone exposure." | 1.42 | Safety of milrinone use in neonatal intensive care units. ( Brian Smith, P; Clark, RH; Hornik, CP; McHutchison, K; Raman, SR; Samiee-Zafarghandy, S; van den Anker, JN, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samiee-Zafarghandy, S | 1 |
| Raman, SR | 1 |
| van den Anker, JN | 1 |
| McHutchison, K | 1 |
| Hornik, CP | 1 |
| Clark, RH | 1 |
| Brian Smith, P | 1 |
| Meyer, S | 1 |
| Mehra, MR | 1 |
| Ventura, HO | 1 |
| Kapoor, C | 1 |
| Stapleton, DD | 1 |
| Zimmerman, D | 1 |
| Smart, FW | 1 |
| Tommaso, CL | 1 |
1 review available for milrinone and Thrombocytopenia
| Article | Year |
|---|---|
Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardi | 1986 |
1 trial available for milrinone and Thrombocytopenia
| Article | Year |
|---|---|
Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.
Topics: Adult; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Drug Administration Schedule; Drug Ther | 1997 |
2 other studies available for milrinone and Thrombocytopenia
| Article | Year |
|---|---|
Safety of milrinone use in neonatal intensive care units.
Topics: Cardiotonic Agents; Female; Humans; Hypotension; Infant, Newborn; Infant, Premature; Intensive Care | 2015 |
Use of milrinone in neonatal intensive care medicine.
Topics: Cardiotonic Agents; Female; Humans; Hypotension; Intensive Care Units, Neonatal; Male; Milrinone; Th | 2015 |